| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |